Promising Chinese Stocks To Keep An Eye On - November 9th

Key Points

• Diageo (DEO), UP Fintech (TIGR), and Regencell Bioscience (RGC) were identified as Chinese-related stocks with the highest recent dollar trading volume, though their businesses range from beverages to brokerage and traditional medicine research.
• Diageo shares rose $1 to $100.77, near their 52-week high of $102.74. UP Fintech was nearly flat at $3.90, close to its 52-week low of $3.61.
• Regencell gained $0.16 to $5.43, but remained far below its 52-week high of $69 and below both its 50-day and 200-day moving averages.

Diageo, UP Fintech, and Regencell Bioscience are the three Chinese stocks to watch today, according to MarketBeat's stock screener tool. “Chinese stocks” are shares of companies based in or closely tied to China, traded on mainland Chinese exchanges or on markets abroad. Investors may encounter them as mainland-listed A-shares or as offshore listings, such as Hong Kong shares and U.S.-listed ADRs; their rules and risks can vary by market. These companies had the highest dollar trading volume of any Chinese stocks within the last several days.

Diageo (DEO)

Diageo plc, together with its subsidiaries, engages in the production, marketing, and sale of alcoholic beverages. The company offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, Chinese white spirits, cachaça, and brandy, as well as beer, including cider and flavored malt beverages. It also provides Chinese, Canadian, Irish, American, and Indian-Made Foreign Liquor whiskies, as well as flavored malt beverages, ready to drink, and non-alcoholic products.

NYSE:DEO traded up $1.00 during mid-day trading on Monday, hitting $100.77. The stock had a trading volume of 638,205 shares, compared to its average volume of 1,444,087. The company has a current ratio of 1.60, a quick ratio of 0.62 and a debt-to-equity ratio of 1.53. The company has a 50 day simple moving average of $90.00 and a 200-day simple moving average of $86.09. Diageo has a 52 week low of $72.45 and a 52 week high of $102.74.

Read Our Latest Research Report on DEO

UP Fintech (TIGR)

UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors. The company has developed a brokerage platform, which allows investor to trade stocks, options, warrants, and other financial instruments that can be accessed through its APP and website. It offers brokerage and value-added services, including investor education, community engagement, and IR platform services.

Shares of NASDAQ:TIGR traded up $0.01 on Monday, hitting $3.90. The company's stock had a trading volume of 722,792 shares, compared to its average volume of 3,085,868. UP Fintech has a 12 month low of $3.61 and a 12 month high of $11.35. The stock's 50-day moving average is $4.46 and its two-hundred day moving average is $5.73. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.10 and a current ratio of 1.10. The company has a market capitalization of $740.77 million, a price-to-earnings ratio of 6.62 and a beta of 0.65.

Read Our Latest Research Report on TIGR

Regencell Bioscience (RGC)

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.

Shares of NASDAQ RGC traded up $0.16 during mid-day trading on Monday, reaching $5.43. 115,299 shares of the company traded hands, compared to its average volume of 294,017. Regencell Bioscience has a fifty-two week low of $4.51 and a fifty-two week high of $69.00. The stock has a fifty day simple moving average of $6.85 and a 200-day simple moving average of $16.60.

Read Our Latest Research Report on RGC

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.